MetLife Investment Management’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Buy |
30,679
+4,098
| +15% | +$165K | 0.01% | 1342 |
|
|
2026
Q1 | $881K | Buy |
26,581
+924
| +4% | +$30K | ﹤0.01% | 1459 |
|
|
2025
Q4 | $840K | Hold |
25,657
| – | – | ﹤0.01% | 1527 |
|
|
2025
Q3 | $458K | Hold |
25,657
| – | – | ﹤0.01% | 1850 |
|
|
2025
Q2 | $278K | Hold |
25,657
| – | – | ﹤0.01% | 2001 |
|
|
2025
Q1 | $475K | Sell |
25,657
-377
| -1% | -$6.8K | ﹤0.01% | 1755 |
|
|
2024
Q4 | $429K | Buy |
26,034
+2,319
| +10% | +$32.8K | ﹤0.01% | 1886 |
|
|
2024
Q3 | $332K | Hold |
23,715
| – | – | ﹤0.01% | 2001 |
|
|
2024
Q2 | $172K | Buy |
23,715
+5,939
| +33% | +$40.6K | ﹤0.01% | 2343 |
|
|
2024
Q1 | $143K | Sell |
17,776
-5,288
| -23% | -$47.4K | ﹤0.01% | 2367 |
|
|
2023
Q4 | $158K | Hold |
23,064
| – | – | ﹤0.01% | 2372 |
|
|
2023
Q3 | $115K | Hold |
23,064
| – | – | ﹤0.01% | 2509 |
|
|
2023
Q2 | $211K | Hold |
23,064
| – | – | ﹤0.01% | 2243 |
|
|
2023
Q1 | $218K | Hold |
23,064
| – | – | ﹤0.01% | 2160 |
|
|
2022
Q4 | $230K | Hold |
23,064
| – | – | ﹤0.01% | 2158 |
|
|
2022
Q3 | $275K | Hold |
23,064
| – | – | ﹤0.01% | 2085 |
|
|
2022
Q2 | $189K | Hold |
23,064
| – | – | ﹤0.01% | 2365 |
|
|
2022
Q1 | $183K | Buy |
23,064
+8,224
| +55% | +$71K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $139K | Buy |
14,840
+4,519
| +44% | +$54.2K | ﹤0.01% | 2278 |
|
|
2021
Q3 | $163K | Sell |
10,321
-5,155
| -33% | -$92.6K | ﹤0.01% | 2208 |
|
|
2021
Q2 | $334K | Hold |
15,476
| – | – | ﹤0.01% | 1819 |
|
|
2021
Q1 | $314K | Hold |
15,476
| – | – | ﹤0.01% | 1789 |
|
|
2020
Q4 | $277K | Hold |
15,476
| – | – | ﹤0.01% | 1808 |
|
|
2020
Q3 | $180K | Hold |
15,476
| – | – | ﹤0.01% | 1920 |
|
|
2020
Q2 | $143K | Hold |
15,476
| – | – | ﹤0.01% | 2077 |
|
|
2020
Q1 | $161K | Hold |
15,476
| – | – | ﹤0.01% | 1810 |
|
|
2019
Q4 | $277K | Hold |
15,476
| – | – | ﹤0.01% | 1805 |
|
|
2019
Q3 | $193K | Hold |
15,476
| – | – | ﹤0.01% | 1970 |
|
|
2019
Q2 | $306K | Sell |
15,476
-30,952
| -67% | -$662K | ﹤0.01% | 1771 |
|
|
2019
Q1 | $978K | Buy |
46,428
+30,952
| +200% | +$565K | ﹤0.01% | 1679 |
|
|
2018
Q4 | $316K | Hold |
15,476
| – | – | ﹤0.01% | 1644 |
|
|
2018
Q3 | $570K | Hold |
15,476
| – | – | 0.01% | 1451 |
|
|
2018
Q2 | $778K | Buy |
15,476
+1,758
| +13% | +$77.5K | 0.01% | 1141 |
|
|
2018
Q1 | $501K | Hold |
13,718
| – | – | 0.01% | 1363 |
|
|
2017
Q4 | $388K | Buy |
+13,718
| New | +$324K | ﹤0.01% | 1552 |
|
Other funds holding AXGN
FLAM
PCH
AIM
WA
MetLife Investment Management's AXGN Position: Q2 2026 in Review
MetLife Investment Management increased its Axogen (AXGN) stake by 15% in Q2 2026, buying an estimated $165K and bringing the position to 30,679 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #1342.
MetLife Investment Management first reported a position in AXGN in Q4 2017 and has held it in 35 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.
- MetLife Investment Management held 30,679 shares of Axogen worth $1.42M as of Q2 2026.
- MetLife Investment Management bought 4,098 Axogen shares in Q2 2026, an estimated $165K.
- Axogen made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1342 holding.
- MetLife Investment Management first reported a position in Axogen in Q4 2017 and has held it in 35 quarters since.
- 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.